SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PLC Systems
PLC 30.130.0%Dec 14 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James A. Winters who wrote (616)4/22/1998 5:13:00 PM
From: pollira  Read Replies (1) of 1202
 
re: FDA panelist short
I believe you misread the FDA report. There was a doctor
who contributed, who stated that he was short, but he was
not on the panel. The panel hears the sponsors (i.e. PLC) give their
data and hears opposing views from doctors and interested others. that doesn't mean that anyone on the (voting) panel had a financial interest.

re: going up or down after (i hope) approval.
there is no good way to tell from the stock movement. Cor therapeutics
last year was a good example. some analysts were saying that its product would compete poorly with Centocor's competing product. Cor
proceeded to go up from 13 to the 20's with some hiccups along the way. Conversely, ATIS recently went down after approval, because people apparently felt that its product would compete poorly against ORG's product.

Here, i think the fact that there would be no competing products on the market yet is in favor of PLC rising after approval.

Ira
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News